IgE Antibody Quantification and the Probability of Wheeze in Preschool Children
Overview
Authors
Affiliations
Background: IgE-mediated sensitization is usually considered a dichotomous variable (either sensitized or not). Quantitative IgE antibody analysis may better predict the expression of wheeze.
Objective: Within the context of a population-based birth cohort, we investigated the association among wheeze, lung function, and specific IgE antibody levels.
Methods: Children (n = 521) were followed to age 5 years with repeated questionnaires, skin testing, and measurement of lung function (specific airway resistance) and specific serum IgE (ImmunoCAP).
Results: Using specific IgE as a continuous variable, the risk of current wheeze increased significantly with increasing IgE to mite, cat, and dog (P < .0001). When IgE levels to these 3 allergens were summed, the probability of current wheeze increased 1.33-fold (95% CI, 1.21-1.47; P < .0001) per logarithmic unit increase, corresponding to an odds ratio of 3.1 at 10 and 4.25 at 30 kU(A)/L (kilo units of Allergen per liter). Similarly, increasing sum of mite-specific, cat-specific, and dog-specific IgE was associated with reduced lung function (P = .004). Among sensitized children (n = 184), the sum of mite, cat, and dog IgE was the strongest associate of current wheeze (odds ratio, 1.28; 95% CI, 1.13-1.46; P < .001), corresponding to an odds ratio of 2.56 at 10 and 3.32 at 30 kU(A)/L. There was no association between current wheeze and the size of skin test wheal. Furthermore, the sum of IgE to mite, cat, and dog at age 3 years increased the risk of persistent wheeze by age 5 years (2.15-fold/logarithmic unit increase in the specific IgE).
Conclusion: IgE-mediated sensitization is not an all or nothing phenomenon. The probability of wheeze and reduced lung function increases with increasing specific IgE antibody levels.
Mahmood F, Hetland G, Mirlashari M, Nissen-Meyer L Scand J Immunol. 2024; 101(1):e13425.
PMID: 39648460 PMC: 11625989. DOI: 10.1111/sji.13425.
Custovic A, Custovic D, Fontanella S Curr Opin Allergy Clin Immunol. 2024; 24(2):79-87.
PMID: 38359101 PMC: 10906203. DOI: 10.1097/ACI.0000000000000967.
Namyslowski A, Lipiec A, Zielinski W, Raciborski F, Krzych-Falta E, Samolinski K Postepy Dermatol Alergol. 2023; 40(5):611-616.
PMID: 38028409 PMC: 10646703. DOI: 10.5114/ada.2023.130287.
Lee Y, Kow A, Jacquet A, Lee M, Tham C Exp Appl Acarol. 2023; 91(4):509-539.
PMID: 37995026 DOI: 10.1007/s10493-023-00857-5.
Li Y, Hu H, Zhang T, Wang G, Huang H, Zheng P J Asthma Allergy. 2021; 14:1185-1195.
PMID: 34616158 PMC: 8488032. DOI: 10.2147/JAA.S322034.